× NICE uses cookies to make the site better.  Learn more
A-Z
Topics
Latest

Hyperglycaemia in acute coronary syndromes

About

What is covered

This pathway covers:
  • the role of intensive insulin therapy in managing hyperglycaemia within the first 48 hours of admission for acute coronary syndromes in people with diagnosed diabetes and people without known diabetes
  • tests for diabetes, lifestyle advice and ongoing monitoring for people without known diabetes.

Updates

Updates to this pathway

29 November 2016 Pathway restructured and summarised recommendations replaced with full recommendations.

Professional responsibilities

The recommendations in this pathway represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients or service users. Applying the recommendations in this pathway is at the discretion of health and care professionals and their individual patients or service users and does not override the responsibility of health and care professionals to make decisions appropriate to the circumstances of the individual, in consultation with them and/or their carer or guardian.
Commissioners and/or providers have a responsibility to enable the recommendations to be applied (and to provide funding required for technology appraisal guidance) when individual health and care professionals and their patients or service users wish to use them. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this pathway should be interpreted in a way that would be inconsistent with compliance with those duties.

Person-centred care

People have the right to be involved in discussions and make informed decisions about their care, as described in your care.
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Short Text

Everything NICE has said on managing hyperglycaemia in people admitted to hospital with acute coronary syndromes in an interactive flowchart

What is covered

This pathway covers:
  • the role of intensive insulin therapy in managing hyperglycaemia within the first 48 hours of admission for acute coronary syndromes in people with diagnosed diabetes and people without known diabetes
  • tests for diabetes, lifestyle advice and ongoing monitoring for people without known diabetes.

Updates

Updates to this pathway

29 November 2016 Pathway restructured and summarised recommendations replaced with full recommendations.

Sources

The NICE guidance that was used to create the pathway.

Quality standards

Quality statements

Effective interventions library

Effective interventions library

Successful effective interventions library details

Implementation

NICE has produced resources to help implement its guidance on:

Information for the public

NICE produces information for the public that summarises, in plain English, the recommendations that NICE makes to healthcare and other professionals.
NICE has written information for the public explaining its guidance on each of the following topics.

Pathway information

Professional responsibilities

The recommendations in this pathway represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients or service users. Applying the recommendations in this pathway is at the discretion of health and care professionals and their individual patients or service users and does not override the responsibility of health and care professionals to make decisions appropriate to the circumstances of the individual, in consultation with them and/or their carer or guardian.
Commissioners and/or providers have a responsibility to enable the recommendations to be applied (and to provide funding required for technology appraisal guidance) when individual health and care professionals and their patients or service users wish to use them. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this pathway should be interpreted in a way that would be inconsistent with compliance with those duties.

Person-centred care

People have the right to be involved in discussions and make informed decisions about their care, as described in your care.
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Supporting information

Glossary

a blood glucose level above 11 mmol/litre
an intravenous infusion of insulin and glucose with or without potassium

Paths in this pathway

Pathway created: October 2011 Last updated: November 2016

© NICE 2016

Recently viewed